Product DescriptionThe Malaysia Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)’s 5 and 10-year forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

Key Benefits- Benchmark BMI’s independent 5 and 10-year pharmaceutical and healthcare industry forecasts on Malaysia to test other views – a key input for successful budgeting and strategic business planning in the Malaysian pharmaceutical and healthcare market.- Target business opportunities and risks in the Malaysian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Malaysia.- Assess the activities, strategy and market position of your competitors, partners and clients via our Company Profiles (inc. SWOTs, KPIs, latest activity) and Competitive Landscape Tables.

Market SummarySnapshot of key market characteristics, including total size of pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape.

Regulatory RegimeDetails of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation, advertising, as well as an analysis of the overall regulatory burden.

Competitive LandscapeCompetitive landscape provides comparative company analyses and rankings by US$ sales, % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Company ProfilesExamining the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of BMI’s industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT (Strengths, Weaknesses, Opportunities and Threats) analyses. Latest financial and operating statistics and key company developments are also incorporated within our company profiles, enabling a full evaluation of recent company performance and future growth prospects.